Literature DB >> 3735548

Duplicated inferior vena cava simulating retroperitoneal lymphadenopathy in a patient with embryonal cell carcinoma of the testicle.

I Klimberg, Z Wajsman.   

Abstract

Computerized tomography has become the most widely applied staging technique in the assessment of retroperitoneal lymph nodes in patients with nonseminomatous testicular carcinoma. Errors in clinical staging of testicular carcinoma can have serious implications for the treatment afforded these patients. We describe a duplicated inferior vena cava that simulated retroperitoneal lymphadenopathy on abdominal computerized tomography in a patient with embryonal cell carcinoma of the testicle. The embryology and implications of anomalous lymphatic drainage of the testicle are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3735548     DOI: 10.1016/s0022-5347(17)45014-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Double inferior vena cava mimicking lymphadenopathy.

Authors:  Taoufik Amezyane; Driss Bassou; Driss Ghafir; Victor Ohayon
Journal:  Ann Saudi Med       Date:  2011 Nov-Dec       Impact factor: 1.526

2.  The iatrogenic injury of double vena cava due to misdiagnosis during the radical nephroureterectomy and cystectomy.

Authors:  Ye-Qing Mao; Shao-Xing Zhu; Wei Zhang
Journal:  World J Surg Oncol       Date:  2015-02-12       Impact factor: 2.754

3.  Retroperitoneal lymph node dissection for testicular cancer in a patient with a double inferior vena cava.

Authors:  Akane Yamaguchi; Hiromitsu Negoro; Kosuke Kojo; Atsushi Ikeda; Tomokazu Kimura; Shuya Kandori; Akio Hoshi; Takahiro Kojima; Koji Kawai; Hiroyuki Nishiyama
Journal:  IJU Case Rep       Date:  2021-01-31

4.  Circumaortic right renal vein with multiple vascular anomalies.

Authors:  Marjeta Tanka; Fjorda Tuka; Erjona Abazaj
Journal:  Radiol Case Rep       Date:  2018-06-07

5.  Wilms tumor with inferior vena cava duplication: a rare case report.

Authors:  Feng Guo; Tianyou Li; Wei Liu; Gang Wang; Rui Ma; Rongde Wu
Journal:  BMC Urol       Date:  2018-10-19       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.